The FDA has granted orphan drug designation to the investigational remedy BA-101 for the remedy of sufferers with glioblastoma.
The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to the investigational remedy BA-101 for the remedy of sufferers with glioblastoma.
The development was introduced in a information launch from NeuroNOS, a biopharmaceutical firm that could be a subsidiary of Past Air and manufactures BA-101.
The FDA, because the company explains on its web site, grants orphan drug designation to a drug or organic product used to stop, diagnose or deal with a uncommon illness or situation, and this designation qualifies sponsors for incentives reminiscent of tax credit for medical trials, exemption from person charges and as many as seven years of market exclusivity after approval.
“Glioblastoma is without doubt one of the commonest and deadliest mind cancers in adults, nevertheless, sufferers have seen little enchancment in remedy choices over the previous a number of a long time. Rising business analysis exhibits that [nitric oxide] is a crucial modulator of organic remedy response in glioblastoma,” stated Amir Avniel, CEO of NeuroNOS, in an announcement included within the information launch. “We consider this information and the pressing unmet medical want have highlighted the chance for our groundbreaking science to develop small molecule therapies that stability nitric oxide ranges within the mind. We consider [a nitric oxide] inhibition technique has the potential to remodel outcomes for sufferers.”
Glioblastoma, as outlined by the Nationwide Most cancers Institute, is a fast-growing kind of central nervous system tumor that types within the supportive glial tissue of the mind and spinal wire and has cells that look very completely different than typical cells. Glioblastoma normally happens in adults and impacts the mind extra usually than the spinal wire.
“Glioblastoma represents a profound unmet want,” stated Prof. Haitham Amal, chief science officer of NeuroNOS, in an announcement of the information launch. “Our revealed papers and unpublished information confirmed a robust hyperlink between [nitric oxide] and [glioblastoma]”.
Amal continued, “We’re dedicated to working intently with regulators, investigators, affected person teams, and foundations to speed up improvement of BA-101 towards first-in-human research.”
Surgical procedure, radiation, and temozolomide chemotherapy are commonplace of take care of sufferers with glioblastoma and might doubtlessly prolong survival, however they don’t remedy glioblastoma, based on the information launch from NeuroNOS. Median survival of the illness is lower than 12 months with two- and five-year survival charges decrease than 20% and 10%, respectively, based on the information launch.
In response to the American Most cancers Society, in 2025 roughly 24,820 malignant tumors of the mind or spinal wire, together with 14,040 in males and 10,780 in females, might be identified. Likewise, about 18,330 individuals, 10,170 males and eight,160 females, will die from mind and spinal wire tumors.
Examine findings in mice revealed earlier this 12 months in Genomic Press: Mind Medication said that “combining BA-101 with the antitumor drug temozolomide (TMZ) synergistically diminished tumor dimension and considerably elevated survivability in mice bearing TMZ-sensitive cells.”
References:
- “NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Widespread and Deadliest Main Malignant Mind Most cancers in Adults,” information launch, Sept. 8, 2025; https://www.globenewswire.com/news-release/2025/09/08/3146057/0/en/NeuroNOS-Granted-FDA-Orphan-Drug-Designation-for-Glioblastoma-the-Most-Widespread-and-Deadliest-Main-Malignant-Mind-Most cancers-in-Adults.html
- “Designating an Orphan Product: Medication and Organic Merchandise,” FDA; https://www.fda.gov/business/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products
- “Glioblastoma,” Nationwide Most cancers Institute; https://www.most cancers.gov/publications/dictionaries/cancer-terms/def/glioblastoma
- “Key Statistics for Mind and Spinal Wire Tumors,” American Most cancers Society; https://www.most cancers.org/most cancers/varieties/brain-spinal-cord-tumors-adults/about/key-statistics.html
For extra information on most cancers updates, analysis and schooling, don’t overlook to subscribe to CURE®’s newsletters right here.
